Evidence map›Paper›PMID 34161817›Full record

ArticleThe Journal of infection2021

Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.

Marie Tré-Hardy, Roberto Cupaiolo, Alain Wilmet, Ingrid Beukinga, Laurent Blairon

Abstract readLetter
In one paragraph

Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Long-term serological SARS-CoV-2 IgG kinetics following mRNA COVID-19 vaccine: real-world data from a large cohort of healthcare workers.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Marie Tré-HardyDepartment of Laboratory Medicine, Iris Hospitals South, rue Jean Paquot 63, Brussels 1050, Belgium; Faculty of Medicine, Université libre de bruxelles, Brussels, Belgium; Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, Belgium. Electronic address: mtrehardy@his-izz.be.
Roberto CupaioloDepartment of Laboratory Medicine, Iris Hospitals South, rue Jean Paquot 63, Brussels 1050, Belgium.
Alain WilmetDepartment of Laboratory Medicine, Iris Hospitals South, rue Jean Paquot 63, Brussels 1050, Belgium.
Ingrid BeukingaDepartment of Laboratory Medicine, Iris Hospitals South, rue Jean Paquot 63, Brussels 1050, Belgium.
Laurent BlaironDepartment of Laboratory Medicine, Iris Hospitals South, rue Jean Paquot 63, Brussels 1050, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-22019-nCoV Vaccine mRNA-1273Antibodies, ViralCOVID-19 VaccinesHealth PersonnelHumansImmunogenicity, Vaccine2019-nCoV Vaccine mRNA-1273Antibodies, ViralCOVID-19 VaccinesCovid-19EfficacyImmunogenicitymRNA-1273 vaccineSARS-CoV-2

Identifiers

PMID34161817
PMCPMC8214908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.